Agache, I., Rocha, C., Beltran, J., Song, Y., Posso, M., Sola, I., . . . Jutel, M. (2020). Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Citación estilo ChicagoAgache, I., et al. Efficacy and Safety of Treatment With Biologicals (benralizumab, Dupilumab and Omalizumab) for Severe Allergic Asthma: A Systematic Review for the EAACI Guidelines - Recommendations On the Use of Biologicals in Severe Asthma. 2020.
Cita MLAAgache, I., et al. Efficacy and Safety of Treatment With Biologicals (benralizumab, Dupilumab and Omalizumab) for Severe Allergic Asthma: A Systematic Review for the EAACI Guidelines - Recommendations On the Use of Biologicals in Severe Asthma. 2020.